` AVTE (Aerovate Therapeutics Inc) vs AMGN (Amgen Inc) Comparison - Alpha Spread

AVTE
vs
AMGN

Over the past 12 months, AVTE has significantly outperformed AMGN, delivering a return of 62% compared to the AMGN's 10% drop.

Valuation Comparison

AVTE Intrinsic Value
94.94 USD
Undervaluation 1%
Intrinsic Value
Price
AMGN Intrinsic Value
263.55 USD
Overvaluation 5%
Intrinsic Value
Price
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
Aerovate Therapeutics Inc
NASDAQ:AVTE
93.8 USD
94.94 USD
Undervalued by 1%
94.94 USD
1% Undervalued
Not Available Not Available
Amgen Inc
NASDAQ:AMGN
277.13 USD
263.55 USD
Overvalued by 5%
259.65 USD
6% Overvalued
267.46 USD
3% Overvalued
320.26 USD
16% Upside

Financials Comparison

Growth Over Time
AVTE vs AMGN

AVTE
AMGN
Add Stock
Revenue
www.alphaspread.com
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
Aerovate Therapeutics Inc
Revenue
Amgen Inc
Revenue

All metrics are calculated based on data from the last 10 years.

Profitability Comparison

Free Cash Flow
AVTE vs AMGN

AVTE
AMGN
Add Stock
Free Cash Flow
www.alphaspread.com
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
Aerovate Therapeutics Inc
NASDAQ:AVTE
Amgen Inc
NASDAQ:AMGN
What is Free Cash Flow?

Gross Margin

AVTE
0%
AMGN
64.1%

Operating Margin

AVTE
0%
AMGN
25.2%

Net Margin

AVTE
0%
AMGN
17.4%

FCF Margin

AVTE
0%
AMGN
32%

ROE

AVTE
-74.9%
AMGN
105.7%

ROA

AVTE
-67%
AMGN
6.5%

ROIC

AVTE
-3 655.6%
AMGN
9.6%

ROCE

AVTE
-79.8%
AMGN
12.3%

Stocks Performance

Stocks Performance
AVTE vs AMGN

Loading

Performance Gap
AVTE vs AMGN

Loading
AVTE
AMGN
Difference
www.alphaspread.com

Performance By Year
AVTE vs AMGN

Loading
AVTE
AMGN
Add Stock
Unlock Full Access to Alpha Spread
Create Free Account